Lupin Shares Surge 7.7% After Launch of Generic Drug in US Market in Top Business News- News18.com published on April 07, 2020 leave a reply The new tablets — the generic version of Novartis Pharmaceuticals Corp’s Myfortic delayed-release tablets — are used to prevent organ rejection in patients receiving kidney transplants. from Top Business News- News18.com https://ift.tt/3e2UU1i Tweet Share Share Share Share Previous Post Gold Falls from One-Month High as Stocks Gain on Virus Slowdown Hopes Next Post Investor Wealth Jumps Rs 4.65 Crore in Morning Trade as Markets Recover post written by: Rohit Related PostsBudget Blues Continue on Dalal Street as BSE Sensex Tanks 250 Points; TCS, HDFC Twins Among Top LosersAfter dropping over 253 points in opening session, the 30-share index pared some losses to trade 152.50 points, or 0.39 per cent, lower at 38,568.07 at 0930 hou… Continue ReadingRupee Falls 18 Paise to 68.84 Against DollarA strengthening dollar against major currencies overseas and weak domestic equity market weighed on the local unit, forex traders said. from Top Business News-… Continue ReadingSugar Output to Fall by 18% as Lower Monsoon Rains Limiting Crop GrowthIndia's sugar production during the 2019-20 marketing year starting from October 1 could fall to 27 million tonnes from 33 million tonnes in 2018-19. from Top … Continue ReadingMindtree, Titan, Yes Bank, Hero MotoCorp Among Key Stocks in News TodayIndian stock markets continued to witness post-budget selloff on Tuesday, with investor sentiment weighed down further by weakness in other Asian markets. The N… Continue ReadingTitan Shares Plunge 14% as High Gold Prices Hit Jewellery Demand in Q1In its quarterly update released on Monday, Titan said that Q1 growth in the jewellery segment stood at a lower-than-expected 13% as sharp increase in gold pric… Continue Reading
0 comments: